Preoperative Bevacizumab in Combination With Paclitaxel and Carboplatin in Surgically Resectable Non-Small Cell Lung Cancer

被引：3
|
作者：
Bertino, Erin [1 ]
Villalona-Calero, Miguel A. [1 ]
Ross, Patrick [2 ]
Grever, Michael [3 ]
Otterson, Gregory A. [3 ]
机构：
[1] Ohio State Univ, Dept Internal Med, Columbus, OH 43210 USA
[2] Ohio State Univ, Dept Surg, Columbus, OH 43210 USA
[3] Ohio State Univ, Dept Internal Med, Columbus, OH 43210 USA
来源：
ANNALS OF THORACIC SURGERY | 2011年 / 91卷 / 02期
关键词：
TRIAL; SURGERY; CHEMOTHERAPY;
D O I：
10.1016/j.athoracsur.2010.07.047
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：640 / 640
页数：1
相关论文
共 50 条
  • [1] Immunotherapy in surgically resectable non-small cell lung cancer
    Owen, Dwight
    Chaft, Jamie E.
    JOURNAL OF THORACIC DISEASE, 2018, 10 : S404 - S411
  • [2] Carboplatin and Paclitaxel With vs Without Bevacizumab in Older Patients With Advanced Non-Small Cell Lung Cancer
    Zhu, Junya
    Sharma, Dhruv B.
    Gray, Stacy W.
    Chen, Aileen B.
    Weeks, Jane C.
    Schrag, Deborah
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2012, 307 (15): : 1593 - 1601
  • [3] Docetaxel-carboplatin in combination with erlotinib and/or bevacizumab in patients with non-small cell lung cancer
    Boutsikou, Eftimia
    Kontakiotis, Theodoros
    Zarogoulidis, Paul
    Darwiche, Kaid
    Eleptheriadou, Ellada
    Porpodis, Konstantinos
    Galaktidou, Grammati
    Sakkas, Leonidas
    Hohenforst-Schmidt, Wolfgang
    Tsakiridis, Kosmas
    Karaiskos, Theodoros
    Zarogoulidis, Konstantinos
    ONCOTARGETS AND THERAPY, 2013, 6 : 125 - 134
  • [4] Comparison of carboplatin and paclitaxel with or without bevacizumab in chemotherapeutic regimens for unresectable stage III non-small cell lung cancer
    Ding, T.
    Li, Z. -T.
    Zhang, X.
    Shi, Y. -T.
    EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, 2017, 21 (16) : 3723 - 3729
  • [5] Efficacy and safety of the combination of paclitaxel, cisplatin and bevacizumab for the treatment of non-small cell lung cancer
    Zhang, Hui
    Fu, Lei
    Jiang, Jingwen
    Fu, Fangfang
    Chen, Aiying
    Gong, Hui
    Zhu, Fengting
    TROPICAL JOURNAL OF PHARMACEUTICAL RESEARCH, 2024, 23 (04) : 769 - 775
  • [6] VEGF in Patients with Non-small Cell Lung Cancer during Combination Chemotherapy of Carboplatin and Paclitaxel
    Shingyoji, Masato
    Ando, Soichiro
    Nishimura, Hiroki
    Nakajima, Takahiro
    Ishikawa, Aki
    Itakura, Meiji
    Iizasa, Toshihiko
    Kimura, Hideki
    ANTICANCER RESEARCH, 2009, 29 (07) : 2635 - 2639
  • [7] Bevacizumab plus Weekly Paclitaxel with or Without Carboplatin for Previously-treated Non-squamous Non-Small Cell Lung Cancer
    Hata, Akito
    Katakami, Nobuyuki
    Tanaka, Kosuke
    Takeshita, Jumpei
    Matsumoto, Takeshi
    Monden, Kazuya
    Nagata, Kazuma
    Masago, Katsuhiro
    Kaji, Reiko
    Fujita, Shiro
    Tachikawa, Ryo
    Otsuka, Kyoko
    Otsuka, Kojiro
    Tomii, Keisuke
    ANTICANCER RESEARCH, 2014, 34 (1A) : 275 - 281
  • [8] Carboplatin plus Weekly Paclitaxel with Bevacizumab for First-line Treatment of Non-small Cell Lung Cancer
    Kubota, Tetsuya
    Okano, Yoshio
    Sakai, Mizu
    Takaoka, Masato
    Tsukuda, Tsukie
    Anabuki, Kazuki
    Kawase, Shigeo
    Miyamoto, Shintaro
    Ohnishi, Hiroshi
    Hatakeyama, Nobuo
    Machida, Hisanori
    Urata, Tomoyuki
    Yamamoto, Akira
    Ogushi, Fumitaka
    Yokoyama, Akihito
    ANTICANCER RESEARCH, 2016, 36 (01) : 307 - 312
  • [9] Multimodality therapy in surgically resectable early non-small cell lung cancer
    Goldberg, M
    IN VIVO, 2000, 14 (01): : 51 - 60
  • [10] Immunotherapy and Vaccination in Surgically Resectable Non-Small Cell Lung Cancer (NSCLC)
    Chiu, Li-Chung
    Lin, Shu-Min
    Lo, Yu-Lun
    Kuo, Scott Chih-Hsi
    Yang, Cheng-Ta
    Hsu, Ping-Chih
    VACCINES, 2021, 9 (07)
12345